Wichita-based Kansas Gastroenterology and New York City-based Columbia University Irving Medical Center have enrolled the first patients in Boomerang Medical’s clinical trial evaluating the use of nerve stimulation as a potential treatment for Crohn’s disease and ulcerative colitis.